Literature DB >> 17637946

Serological evidence of hepatitis E virus infection in an indigenous North American population.

G Y Minuk1, A Sun, D F Sun, J Uhanova, L E Nicolle, B Larke, A Giulivi.   

Abstract

BACKGROUND: Hepatitis E virus (HEV) infections are thought to be uncommon in North America. Recently, HEV transmission has been reported following the consumption of deer meat. Because deer are closely related to caribou and caribou meat is a staple of the Canadian Inuit and the American Eskimo diet, the present study explored the seroprevalence of HEV infection in an isolated Canadian Inuit community.
METHODS: Stored sera were thawed and tested for immunoglobulin (Ig) G and IgM anti-HEV by ELISA, and tested for HEV-RNA by reverse transcriptase polymerase chain reaction.
RESULTS: The study consisted of 393 sera (representing approximately 50% of the community's inhabitants). Eleven samples (3%) were IgG anti-HEV-positive. Their mean age was 29+/-8 years and three were male. Two of 11 (18%) were also IgM anti-HEV-positive. All IgG anti-HEV-positive individuals were HEV-RNA-negative. Liver biochemistry was normal in all. Seven of 11 (64%) were also positive for anti-hepatitis A virus, five (46%) were hepatitis B virus seropositive and none (0%) were positive for anti-hepatitis C virus. There were no associations between infections with HEV and other hepatropic viruses. Serological testing was negative for HEV infection in 25 caribou from an adjacent region.
CONCLUSION: The results of the present study showed that serological evidence of HEV infection was present in 3% of the observed Canadian Inuit population; the presence of IgM anti-HEV suggested recent infection and HEV did not appear to coinfect with other common hepatotropic viruses. The source of HEV infection in the population remains unclear. These findings are interesting but preliminary. Additional data are required to determine whether HEV infections are responsible for otherwise unexplained acute hepatitis in the Canadian Inuit population and visitors returning from northern North American communities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17637946      PMCID: PMC2657964          DOI: 10.1155/2007/289059

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  21 in total

1.  Natural history and risk factors in fulminant hepatic failure.

Authors:  U Poddar; B R Thapa; A Prasad; A K Sharma; K Singh
Journal:  Arch Dis Child       Date:  2002-07       Impact factor: 3.791

2.  Hepatitis E in the south west of France in individuals who have never visited an endemic area.

Authors:  Jean Michel Mansuy; Jean Marie Peron; Florence Abravanel; Hélène Poirson; Martine Dubois; Marcel Miedouge; Françoise Vischi; Laurent Alric; Jean Pierre Vinel; Jacques Izopet
Journal:  J Med Virol       Date:  2004-11       Impact factor: 2.327

3.  Stability of lyophilised specimens for the molecular detection of viral DNA/RNA.

Authors:  Helen Vaughan; Victoria J Chalker; Zoe Mee; Anneline Rossouw; Vivienne James
Journal:  J Clin Virol       Date:  2005-07-18       Impact factor: 3.168

4.  Blood-borne pathogens routine surveillance system report.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2002-07

5.  IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein.

Authors:  M O Favorov; Y E Khudyakov; E E Mast; T L Yashina; C N Shapiro; N S Khudyakova; D L Jue; G G Onischenko; H S Margolis; H A Fields
Journal:  J Med Virol       Date:  1996-09       Impact factor: 2.327

6.  Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan.

Authors:  Hitoshi Mizuo; Kazuyuki Suzuki; Yasuhiro Takikawa; Yoshiki Sugai; Hajime Tokita; Yoshihiro Akahane; Keiichi Itoh; Yuhko Gotanda; Masaharu Takahashi; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

7.  ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates.

Authors:  S A Tsarev; T S Tsareva; S U Emerson; A Z Kapikian; J Ticehurst; W London; R H Purcell
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

8.  Hepatitis E in pregnancy.

Authors:  A Kumar; M Beniwal; P Kar; J B Sharma; N S Murthy
Journal:  Int J Gynaecol Obstet       Date:  2004-06       Impact factor: 3.561

9.  Zoonotic transmission of hepatitis E virus from deer to human beings.

Authors:  Shuchin Tei; Naoto Kitajima; Kazuaki Takahashi; Shunji Mishiro
Journal:  Lancet       Date:  2003-08-02       Impact factor: 79.321

10.  Hepatitis E virus sequences in swine related to sequences in humans, The Netherlands.

Authors:  W H van der Poel; F Verschoor; R van der Heide; M I Herrera; A Vivo; M Kooreman; A M de Roda Husman
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

View more
  12 in total

1.  Hepatitis E virus seroprevalence before hematopoietic SCT: a pediatric experience.

Authors:  M Jaber; K Béland; C Rousseau; S Cellot; U Halac; F Alvarez; C Buteau
Journal:  Bone Marrow Transplant       Date:  2014-03-17       Impact factor: 5.483

2.  First Crystal Structure of a Nonstructural Hepatitis E Viral Protein Identifies a Putative Novel Zinc-Binding Protein.

Authors:  Andrew Proudfoot; Anastasia Hyrina; Meghan Holdorf; Andreas O Frank; Dirksen Bussiere
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

3.  Spatial configuration of hepatitis E virus antigenic domain.

Authors:  Li Xing; Joseph C Wang; Tian-Cheng Li; Yasuhiro Yasutomi; James Lara; Yury Khudyakov; Darren Schofield; Suzanne U Emerson; Robert H Purcell; Naokazu Takeda; Tatsuo Miyamura; R Holland Cheng
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

4.  Identification of the interferon-inducible GTPase GBP1 as major restriction factor for the Hepatitis E virus.

Authors:  Mirco Glitscher; Kiyoshi Himmelsbach; Kathrin Woytinek; Anja Schollmeier; Reimar Johne; Gerrit J K Praefcke; Eberhard Hildt
Journal:  J Virol       Date:  2021-01-20       Impact factor: 5.103

5.  Neglected infections of poverty among the indigenous peoples of the arctic.

Authors:  Peter J Hotez
Journal:  PLoS Negl Trop Dis       Date:  2010-01-26

Review 6.  Chronic liver disease in Aboriginal North Americans.

Authors:  John D Scott; Naomi Garland
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

Review 7.  Molecular biology and replication of hepatitis E virus.

Authors:  Dianjun Cao; Xiang-Jin Meng
Journal:  Emerg Microbes Infect       Date:  2012-08-22       Impact factor: 7.163

Review 8.  Light and Darkness: Prevalence of Hepatitis E Virus Infection among the General Population.

Authors:  José-Manuel Echevarría
Journal:  Scientifica (Cairo)       Date:  2014-02-10

9.  Burden and prevention of viral hepatitis in the Arctic region, Copenhagen, Denmark, 22-23 March 2012.

Authors:  David FitzSimons; Brian McMahon; Greet Hendrickx; Alex Vorsters; Pierre Van Damme
Journal:  Int J Circumpolar Health       Date:  2013-07-17       Impact factor: 1.228

10.  Inhibition of Hepatitis E Virus Spread by the Natural Compound Silvestrol.

Authors:  Mirco Glitscher; Kiyoshi Himmelsbach; Kathrin Woytinek; Reimar Johne; Andreas Reuter; Jelena Spiric; Luisa Schwaben; Arnold Grünweller; Eberhard Hildt
Journal:  Viruses       Date:  2018-06-02       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.